Pier G. Cerasuolo

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

LC-OCT for Cutaneous Lupus Erythematosus: Characterization Across Disease Subtypes and Differentiation From Rosacea.

LC-OCT for Cutaneous Lupus Erythematosus: Characterization Across Disease Subtypes and Differentiation From Rosacea.

Journal: Experimental dermatology

Published: June 17, 2026

Comment on: Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework: reply.

Comment on: Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework: reply.

Journal: Rheumatology (Oxford, England)

Published: April 16, 2026

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework.

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework.

Journal: Rheumatology (Oxford, England)

Published: August 31, 2025

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY.

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY.

Journal: Arthritis care & research

Published: May 02, 2025

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

Journal: Arthritis care & research

Published: May 02, 2025

Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression.

Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression.

Journal: American journal of respiratory and critical care medicine

Published: July 30, 2024

How to survive on Mediterranean coastal cliffs: tolerance to seawater in early life-cycle stages in Brassica incana Ten. (Brassicaceae).

How to survive on Mediterranean coastal cliffs: tolerance to seawater in early life-cycle stages in Brassica incana Ten. (Brassicaceae).

Journal: Plant biology (Stuttgart, Germany)

Published: March 05, 2024

Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.

Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.

Journal: Joint bone spine

Published: July 01, 2022

Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.

Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.

Journal: Microvascular research

Published: March 02, 2022

Silent acro-osteolysis in a patient with psoriatic disease and recurrent micro-trauma.

Silent acro-osteolysis in a patient with psoriatic disease and recurrent micro-trauma.

Journal: Rheumatology (Oxford, England)

Published: August 09, 2021

Adult-onset Still's disease following COVID-19 vaccination.

Adult-onset Still's disease following COVID-19 vaccination.

Journal: The Lancet. Rheumatology

Published: July 28, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026